AIMC Topic: Hyperthermic Intraperitoneal Chemotherapy

Clear Filters Showing 1 to 3 of 3 articles

Predicting Postoperative Infection After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy with Splenectomy.

Annals of surgical oncology
BACKGROUND: Hematologic changes after splenectomy and hyperthermic intraperitoneal chemotherapy (HIPEC) can complicate postoperative assessment of infection. This study aimed to develop a machine-learning model to predict postoperative infection afte...

A machine learning approach for predicting textbook outcome after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

World journal of surgery
INTRODUCTION: Peritoneal carcinomatosis is considered a late-stage manifestation of neoplastic diseases. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) can be an effective treatment for these patients. However, the p...

Predicting Severe Postoperative Complications after CRS-HIPEC: An Externally Validated Machine-Learning Tool.

World journal of surgery
INTRODUCTION: Current decision support tools designed to predict postoperative complications, following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC), are limited by small sample sizes and lack of external validatio...